Anish Suri, PRESIDENT AND CSO at Cue Biopharma, Inc. (CUE), bought 4,000 shares at $2.76 ($11K) on 2023-08-25, disclosed to the SEC on 2023-08-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| CUE | SELL | 2021-09-27 | $305K | — | Filing → |
| CUE | SELL | 2020-08-07 | $16K | — | Filing → |
| CUE | SELL | 2020-08-05 | $240K | — | Filing → |